Medtronic's PulseSelect PFA System Gets FDA Nod, Revolutionizing Atrial Fibrillation Treatment in US - Medtronic (NYSE:MDT)

The FDA approved Medtronic plc's (NYSE: MDT) PulseSelect Pulsed Field Ablation (PFA) System for the treatment of both paroxysmal and persistent atrial fibrillation (AF), an irregular and often 

Related Keywords

,Medtronic Pulseselect ,Medtronic Symplicity Spyral ,Medtronic ,Select Pulsed Field Ablation ,Symplicity Spyral ,